Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. has demonstrated a positive financial trajectory with a gross margin increase of approximately 80 basis points year-over-year, reaching 79.8% in the second quarter of 2025. Revenue for the same quarter rose about 23% year-over-year to $46.4 million, highlighting a strong demand for its innovative medical devices. Additionally, the company expanded its surgeon base by approximately 25% year-over-year, contributing to a production increase of $2.1 million, also up about 23% year-over-year, indicating robust market traction for its products.

Bears say

SI-BONE Inc faces significant challenges in the global spine market, which has been experiencing pricing and procedure headwinds that have resulted in low-single-digit growth in recent years. These persistent headwinds threaten SI-BONE's market share in the sacroiliac joint fusion market, particularly if payors opt to reimburse for competing products, potentially leading to a decline in the company's top-line revenue. Furthermore, industry-wide expectations suggest that these difficulties are likely to persist, contributing to a depressed outlook for overall market growth.

SI-BONE Inc (SIBN) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 4 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.